Evidence map›Paper›PMID 42236981›Full record

ArticleEMBO molecular medicine2026

Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin deficient mice.

Andrea Farini, Luana Tripodi, Chiara Villa, Francesco Strati, Amanda Facoetti, Guido Baselli, Jacopo Troisi, Annamaria Landolfi, Caterina Lonati, Davide Molinaro and 7 more

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Andrea FariniStem Cell Laboratory, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Unit of Neurology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Centro Dino Ferrari, Milan, Italy.ORCID 0000-0002-8514-4921
Luana TripodiStem Cell Laboratory, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Unit of Neurology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Centro Dino Ferrari, Milan, Italy.ORCID 0000-0003-4446-2840
Chiara VillaStem Cell Laboratory, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Unit of Neurology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Centro Dino Ferrari, Milan, Italy.
Francesco StratiMucosal Immunology Lab, Department of Experimental Oncology, IEO-European Institute of Oncology, Milano, Italy.ORCID 0000-0001-7217-3355
Amanda FacoettiHumanitas University, Milan, Italy.
Guido BaselliTranslational Medicine - Department of Transfusion Medicine and Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Jacopo TroisiDepartment of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, Italy.ORCID 0000-0003-2962-7379
Annamaria LandolfiDepartment of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, Italy.ORCID 0000-0002-4975-4722
Caterina LonatiCenter for Surgical Research, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Davide MolinaroStem Cell Laboratory, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Unit of Neurology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Centro Dino Ferrari, Milan, Italy.ORCID 0000-0001-7536-208X
Michelle WintzingerMolecular Cardiovascular Biology Division, Heart Institute, Cincinnati Children's Hospital Medical Center, and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Stefano GattiCenter for Surgical Research, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0000-0003-2209-4338
Barbara CassaniDepartment of Medical Biotechnologies and Translational Medicine, Università Degli Studi di Milano, Milan, Italy.
Flavio CaprioliDepartment of Pathophysiology and Transplantation, Università degli Studi di Milano, Unit of Gastroenterology and Endoscopy, Fondazione IRCCS Ca' Granda, Ospedale Policlinico di Milano, Milano, Italy.
Federica FacciottiDepartment of Pathophysiology and Transplantation, Università degli Studi di Milano, Unit of Gastroenterology and Endoscopy, Fondazione IRCCS Ca' Granda, Ospedale Policlinico di Milano, Milano, Italy.
Mattia QuattrocelliMolecular Cardiovascular Biology Division, Heart Institute, Cincinnati Children's Hospital Medical Center, and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Yvan TorrenteStem Cell Laboratory, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Unit of Neurology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Centro Dino Ferrari, Milan, Italy. yvan.torrente@unimi.it.ORCID 0000-0002-2705-3984

Funding

Glucocorticoid and circadian clock coregulation of insulin sensitivity and metabolismK01DK121875 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI QUATTROCELLI, MATTIA · 2019 to 2021
$444k
Cincinnati Children's Hospital Medical Center (CCHMC) Heart Institute Translational FundsCincinnati Children's Hospital Medical Center (CCHMC) Start-up fundsFondazione Cariplo (Cariplo Foundation) Premio Ricerca Biomedica FondazioneFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (Policlinico of Mila) 5X1000Fondo Europeo di Sviluppo Regionale 2014-2020GFB-ONLUS PR-0394HHS | National Institutes of Health (NIH) DK121875NIDDK NIH HHS K01 DK121875PNRR M6/C2_CALL 2022 PNRR-MAD-2022-12376828)Ricerca Innovazione and Gruppo familiari beta-sarcoglicanopatie POR FESR 2014-2020
6 · The paper itself

Abstract

Duchenne muscular dystrophy (DMD) is a progressive, severe muscle-wasting disease caused by mutations in DMD, encoding dystrophin, that leads to loss of muscle function with cardiac/respiratory failure and premature death. Since dystrophic muscles are sensed by infiltrating inflammatory cells, and gut microbial communities can cause immune dysregulation and metabolic syndrome, we sought to investigate whether intestinal bacteria support the muscle immune response in the mdx dystrophic murine model. We highlighted a strong correlation between DMD disease features and the relative abundance of Prevotella. Furthermore, the absence of gut microbes through the generation of mdx germ-free animal model, as well as modulation of the microbial community structure by antibiotic treatment, influenced muscle immunity and fibrosis. Intestinal colonization of mdx mice with eubiotic microbiota was sufficient to reduce inflammation and improve muscle pathology and function. This work identifies a potential role for the gut microbiota in the pathogenesis of DMD.

Indexed as

DysbiosisDystrophinGastrointestinal MicrobiomeMuscle, SkeletalMuscular Dystrophy, DuchenneAnimalsDisease Models, AnimalMiceMice, Inbred mdxDystrophin

Identifiers

PMID42236981
PMCPMC13365508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.